SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-130276 from BRIGHTHOUSE LIFE INSURANCE Co (CIK 0000733076)

BRIGHTHOUSE LIFE INSURANCE Co (CIK 0000733076)
Date: May 3, 2024 · CIK: 0000733076 · Accession: 0001193125-24-130276

AI Filing Summary & Sentiment

File numbers found in text: 333-268427, 333-276599, 333-276762

Date
May 3, 2024
Author
BRIGHTHOUSE LIFE INSURANCE COMPANY
Form
CORRESP
Company
BRIGHTHOUSE LIFE INSURANCE Co (CIK 0000733076)

Letter

333-276762 Selective Review

VIA EDGAR TRANSMISSION

U.S. Securities and Exchange Commission

100 F Street, NE

Washington, DC 20549

Attn: Sonny Oh, Esq.

Senior Counsel, Division of Investment Management –

Disclosure Review and Accounting Office

May 3, 2024

Re: Request for Selective Review

Brighthouse Life Insurance Company

Brighthouse Shield® Level II Advisory Annuity (File No. 333-276762)

To the Commission:

On January 30, 2024, Brighthouse Life Insurance Company (the “Company”) filed an initial registration statement on Form S-3 (File No. 333-276762) for certain individual single premium deferred index-linked separate account annuity contracts referred to as the Brighthouse Shield® Level II Advisory Annuity (the “Advisory II Annuity,” and the registration statement on Form S-3, the “Advisory II Annuity Registration Statement”). The Advisory II Annuity is one of a series of “Generation II” Shield contracts that incorporate a new method of valuation necessitated by certain recent state insurance regulatory changes.

The Company is in the process of filing registration statements for the Generation II Shield contracts. The Company filed the first such registration statement on Form S-3 on January 19, 2024. The registration statement (File No. 333-276599) relates to the Brighthouse Shield® Level II 6-Year Annuity (the “Shield II 6-Year Annuity,” and the registration statement on Form S-3, the “Shield II 6-Year Registration Statement”). The Staff reviewed and provided comments on the prospectus included in the Shield II 6-Year Registration Statement. The Company responded to the Staff’s comments on April 24, 2024 in an EDGAR correspondence filing that included a revised prospectus reflecting the Staff’s comments (the “Revised Shield II 6-Year Annuity Prospectus”).

The Company has now revised the prospectus included in the Advisory II Annuity Registration Statement to reflect those same comments, where applicable (the “Revised Advisory II Annuity Prospectus”). The revised prospectus is included herewith. The Company requests selective review of the Revised Advisory II Annuity Prospectus because virtually all of the disclosure in the prospectus has been reviewed by the Staff in one context or another as described below.

The basic “framework” of the Revised Advisory II Annuity Prospectus is substantively similar to the prospectus included in the current registration statement for the first generation of the Shield Advisory Annuity, the Brighthouse Shield® Level Select Advisory Annuity (the “Advisory Annuity”) (File No. 333-268427), previously reviewed by the Staff and declared effective on March 16, 2023.

Certain disclosure in the Revised Advisory II Annuity Prospectus is substantively similar to disclosure that was at one time included in supplements to prospectuses for the Advisory Annuity. This disclosure relates primarily to the following information:

Step Rate Edge rate crediting type

Expanded term length options

Nasdaq-100 Index®

Annuity Service Office contact information change

Information regarding the SECURE 2.0 Act of 2022

Remaining disclosure in the Revised Advisory II Annuity Prospectus is substantively similar to disclosure in the Revised Shield II 6-Year Annuity Prospectus relating to new Contract features:

New Interim Value calculation method

New version of Performance Lock feature

Addition of Holding Account

Uncapped Cap Rate

In this regard, the Company represents that it will make additional disclosure changes to the Revised Advisory II Annuity Prospectus, where applicable, relating to any additional comments provided to the Company by the Staff in connection with its continued review of the Revised Shield II 6-Year Annuity Prospectus.

Accordingly, because the Revised Advisory II Annuity Prospectus will provide only very limited new material for review by the Staff, the Company requests that it be accorded selective review by the Staff. In this connection, the Company represents that if the Revised Advisory II Annuity Prospectus were included in a post-effective amendment eligible to be filed pursuant to Rule 485 under the 1933 Act, the Company would file the amendment pursuant to Rule 485(b) because it does not include any material disclosure that has not already been reviewed by the Staff.

If you have any questions or comments regarding this request for selective review, please call Tom Conner of Carlton Fields at (202) 965-8139.

Sincerely,
BRIGHTHOUSE LIFE INSURANCE COMPANY

Show Raw Text
CORRESP
1
filename1.htm

333-276762 Selective Review

 VIA EDGAR TRANSMISSION

U.S. Securities and Exchange Commission

 100 F Street, NE

Washington, DC 20549

 Attn: Sonny Oh, Esq.

Senior Counsel, Division of Investment Management –

Disclosure Review and Accounting Office

 May 3, 2024

Re:
 Request for Selective Review

 
 Brighthouse Life Insurance Company

 
 Brighthouse Shield® Level II Advisory
Annuity (File No. 333-276762)

 To the Commission:

On January 30, 2024, Brighthouse Life Insurance Company (the “Company”) filed an initial registration
statement on Form S-3 (File No. 333-276762) for certain individual single premium deferred index-linked separate account annuity contracts referred to as the
Brighthouse Shield® Level II Advisory Annuity (the “Advisory II Annuity,” and the registration statement on Form S-3, the “Advisory II
Annuity Registration Statement”). The Advisory II Annuity is one of a series of “Generation II” Shield contracts that incorporate a new method of valuation necessitated by certain recent state insurance regulatory changes.

The Company is in the process of filing registration statements for the Generation II Shield contracts. The Company filed the
first such registration statement on Form S-3 on January 19, 2024. The registration statement (File No. 333-276599) relates to the Brighthouse Shield® Level II 6-Year Annuity (the “Shield II 6-Year
Annuity,” and the registration statement on Form S-3, the “Shield II 6-Year Registration Statement”). The Staff reviewed and provided comments on the
prospectus included in the Shield II 6-Year Registration Statement. The Company responded to the Staff’s comments on April 24, 2024 in an EDGAR correspondence filing that included a revised
prospectus reflecting the Staff’s comments (the “Revised Shield II 6-Year Annuity Prospectus”).

The Company has now revised the prospectus included in the Advisory II Annuity Registration Statement to reflect those same
comments, where applicable (the “Revised Advisory II Annuity Prospectus”). The revised prospectus is included herewith. The Company requests selective review of the Revised Advisory II Annuity Prospectus because virtually all of the
disclosure in the prospectus has been reviewed by the Staff in one context or another as described below.

•

 The basic “framework” of the Revised Advisory II Annuity Prospectus is substantively similar to the
prospectus included in the current registration statement for the first generation of the Shield Advisory Annuity, the Brighthouse Shield® Level Select Advisory Annuity (the “Advisory
Annuity”) (File No. 333-268427), previously reviewed by the Staff and declared effective on March 16, 2023.

•

 Certain disclosure in the Revised Advisory II Annuity Prospectus is substantively similar to disclosure that
was at one time included in supplements to prospectuses for the Advisory Annuity. This disclosure relates primarily to the following information:

○

 Step Rate Edge rate crediting type

○

 Expanded term length options

○

 Nasdaq-100 Index®

○

 Annuity Service Office contact information change

○

 Information regarding the SECURE 2.0 Act of 2022

•

 Remaining disclosure in the Revised Advisory II Annuity Prospectus is substantively similar to disclosure in
the Revised Shield II 6-Year Annuity Prospectus relating to new Contract features:

○

 New Interim Value calculation method

○

 New version of Performance Lock feature

○

 Addition of Holding Account

○

 Uncapped Cap Rate

In this regard, the Company represents that it will make additional disclosure changes to the Revised Advisory II Annuity
Prospectus, where applicable, relating to any additional comments provided to the Company by the Staff in connection with its continued review of the Revised Shield II 6-Year Annuity Prospectus.

Accordingly, because the Revised Advisory II Annuity Prospectus will provide only very limited new material for review by the
Staff, the Company requests that it be accorded selective review by the Staff. In this connection, the Company represents that if the Revised Advisory II Annuity Prospectus were included in a post-effective amendment eligible to be filed pursuant to
Rule 485 under the 1933 Act, the Company would file the amendment pursuant to Rule 485(b) because it does not include any material disclosure that has not already been reviewed by the Staff.

If you have any questions or comments regarding this request for selective review, please call Tom Conner of Carlton Fields
at (202) 965-8139.

 Sincerely,

BRIGHTHOUSE LIFE INSURANCE COMPANY

By: /s/ Michele H. Abate

Name: Michele H. Abate

Title:   Vice President and Associate General Counsel

 Page 2 of 2